Article
Basic science and research in renal cell carcinoma: from workbench to bedside.
Current opinion in urology - 1 Nov 2003
Heidenreich Axel, Schrader Andres J, Varga Zoltan
Abstract excerpt
PURPOSE OF REVIEW: Renal cell carcinoma represents the third most common cancer in men. Radical surgery remains the only curative approach, and the 5-year survival rate once the cancer has metastasized rarely exceeds 20% despite systemic therapy. It becomes evident that an improvement in outcome might only be achieved if (1) there is early diagnosis, (2) there is accurate prediction of progression and response,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
